Regarding the proper treatment of ginger in a dose of 1000 mg per day and the probability of some tolerable complications, the aim of this study is to reduce the consumption of ginger to 500 mg per day by co-administration with vitamin B6.
This study is conducted on pregnant women with nausea problems that are present in their first 17 weeks of pregnancy. Criteria for entering the study are: a person with no other underlying illnesses, no other medications, No history of hospitalization for severe nausea and vomiting, lack of hyperemesis gravid arum, lack of allergy to ginger or vitamin B6 and lack of twin pregnancy or Multiplier.
Exit criteria include serious adverse effects, very severe nausea, or using other anti-nausea drugs.
Study is conducted in three groups: 40mg b6, 40mg b6+500mg ginger, 40mg b6+1000mg ginger per day. Each group consists of 80 people.
At beginning of the assessment, the consent is filled up by the individual before the drug is started.
The day of referral to the treatment center is a questionnaire filled with a person's personal information (age, degree of education, ...), degree of nausea and vomiting within 24 hours before starting treatment. The medication is delivered and the information is collected for a period of 4 days by the SMS panel or the telephone number of the person who reports the condition of the nausea and vomiting condition.